Capricor Stock: I Rate It A Buy After Stress-Testing The Sell Thesis (NASDAQ:CAPR)
Looking for a portfolio of ideas like this one? Members of The Total Pharma Tracker get exclusive access to our subscriber-only portfolios. Learn More " Every recent article on Seeking Alpha about Capricor (CAPR) is a Buy or a Hold – except that one Sell article from December. So I checked out the article, and I found the argument Dubai-based…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
 Looking for a portfolio of ideas like this one? Members of The Total Pha){kind=link}